InsiderSignal.AI

InsiderSignal.ai

STSS - Sharps Technology Inc.

Insider Purchase by Hayes Robert Michael (Dir)

1 Year
After Trade
Before Trade

Loading data...

Trade Summary

6 months ago, Hayes Robert Michael, serving as Dir at Sharps Technology Inc. (STSS), purchased 100,000 shares at $6.41 per share, for a total transaction value of $641,000.00. Following this transaction, Hayes Robert Michael now holds 100,000 shares of STSS.

The trade was executed on Friday, August 22, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, August 26, 2025, 4 days after the trade was made.

Sharps Technology Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL INSTRUMENTS & SUPPLIES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Hayes Robert Michael

Dir

Robert Michael Hayes (also referred to as Robert M. Hayes or Robert Hayes) is a Director at Sharps Technology Inc. (STSS), an innovative medical device company specializing in patented smart-safety syringes and pharmaceutical packaging with ultra-low waste features and a manufacturing facility in Hungary.[[2]](https://www.gurufocus.com/insider/177132/robert-michael-hayes)[[3]](https://www.quiverquant.com/news/Sharps+Technology,+Inc.+CEO+Robert+Hayes+to+Present+at+Aegis+Capital+Corp.+2025+Virtual+Conference+on+May+22) He owns approximately 100,000 shares of STSS stock, valued at over $189,000 as of recent data, and has been active as a corporate insider with multiple purchases totaling 305,000 shares.[[2]](https://www.gurufocus.com/insider/177132/robert-michael-hayes)[[3]](https://www.quiverquant.com/news/Sharps+Technology,+Inc.+CEO+Robert+Hayes+to+Present+at+Aegis+Capital+Corp.+2025+Virtual+Conference+on+May+22) Hayes served as Chief Executive Officer (CEO) of Sharps Technology until his resignation on August 23, 2025, after which he continued in his role as Director.[[1]](https://www.marketscreener.com/news/sharps-technology-inc-announces-resignation-of-robert-m-hayes-as-chief-executive-officer-effecti-ce7c50dcdb8bf52c)[[3]](https://www.quiverquant.com/news/Sharps+Technology,+Inc.+CEO+Robert+Hayes+to+Present+at+Aegis+Capital+Corp.+2025+Virtual+Conference+on+May+22) A dynamic executive with over 30 years of experience in the healthcare packaging and medical device industries, he has driven key initiatives including partnerships like the distribution agreement with Nephron Pharmaceuticals and presentations at investor conferences such as the Aegis Capital Corp. 2025 Virtual Conference.[[5]](https://www.youtube.com/watch?v=O3fhlNxXS68)[[7]](https://us.bold.pro/my/robert-hayes-250812111449)[[3]](https://www.quiverquant.com/news/Sharps+Technology,+Inc.+CEO+Robert+Hayes+to+Present+at+Aegis+Capital+Corp.+2025+Virtual+Conference+on+May+22) His leadership emphasized innovation, cost reduction in healthcare, and leveraging industry relationships to advance the company's products, which are FDA-approved, CE-marked, and WHO-approved.[[5]](https://www.youtube.com/watch?v=O3fhlNxXS68)

View full insider profile →

Trade Price

$6.41

Quantity

100,000

Total Value

$641,000.00

Shares Owned

100,000

Trade Date

Friday, August 22, 2025

184 days ago

SEC Filing Date

Tuesday, August 26, 2025

Filed 4 days after trade

HEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES

About Sharps Technology Inc.

Company Overview

No company information available
View news mentioning STSS

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/157223

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime